Pregnancy brings significant metabolic changes, including a roughly 50% increase in the production of thyroid hormones and a higher daily requirement for iodine [7]. These shifts can enlarge the thyroid gland by up to 20% even in areas with sufficient iodine [7]. When a pregnant individual has preexisting or new thyroid disease—whether an excess or a deficiency of hormones—the risk profile of the pregnancy changes significantly [4]. Both overt and subclinical thyroid disorders require careful clinical attention because they can influence both maternal health and fetal development [1].
Hyperthyroidism and Hypothyroidism Risks
Both thyrotoxicosis (excess thyroid hormone) and hypothyroidism (insufficient thyroid hormone) are strongly associated with adverse pregnancy outcomes [1]. An abnormal balance of thyroid hormones raises the risk of complications such as preeclampsia, preterm birth, and placental problems [4]. Furthermore, untreated thyroid disease can cause thyroid derangements in the fetus and neonate, while medications used to treat maternal thyroid conditions can cross the placenta and directly affect the fetal thyroid gland [1], [4]. Autoimmune thyroid disease, which affects up to 2% to 5% of pregnant women, is also linked to an increased risk of infertility, miscarriage, and decreased fetal development, often remaining asymptomatic and undetected without proper testing [8].
Impact on Fetal Neurodevelopment
There is considerable concern regarding the effect of overt maternal thyroid disease on fetal development and long-term neurocognition [1], [4]. Mild thyroid hypofunction during pregnancy has similarly been linked to poor neurocognitive outcomes in offspring [6]. Because fetal development depends heavily on adequate hormone regulation during early gestation, managing these metabolic states is a vital part of prenatal care [1]. Close and tight management of thyroid conditions within the fluctuating physiological environment of pregnancy can significantly improve perinatal outcomes [4].
Screening and Diagnosis Controversies
Health authorities continue to discuss the best ways to diagnose and monitor thyroid issues during pregnancy. Professional medical societies generally recommend a case-finding approach, testing only high-risk women for thyroid dysfunction rather than implementing universal screening [5]. This selective strategy is chosen because, although subclinical hypothyroidism is linked to obstetric complications, evidence that routine levothyroxine treatment reverses these risks remains limited [5]. However, some studies estimate that targeted testing misses between 30% and 55% of hypothyroidism cases in pregnant women, leading some researchers to advocate for universal screening [5]. Clinicians rely on appropriate, pregnancy-specific reference ranges to interpret lab results accurately [6].
Management and Preconception Counseling
Preconception counseling and care for individuals with known thyroid conditions help optimize health before pregnancy occurs [6]. Overt thyroid dysfunction demands careful consideration of medication adjustments and close clinical monitoring [6]. Because pregnancy alters normal laboratory values, understanding underlying physiological shifts allows healthcare providers to care for patients effectively [3], [7]. Through early detection and specialized clinical management, many of the serious complications associated with maternal thyroid dysfunction can be successfully prevented [5], [8].
Sources
- 1. Thyroid Disease in Pregnancy: ACOG Practice Bulletin, Number 223
- 2. Thyroid Disease in Pregnancy: ACOG Practice Bulletin Summary, Number 223
- 3. Thyroid disease in pregnancy
- 4. Preexisting Thyroid Disease in Pregnancy: A Brief Overview
- 5. Update on the Management of Thyroid Disease during Pregnancy
- 6. Preconception Counseling and Care for Pregnant Women with Thyroid Disease
- 7. Thyroid Disease and Pregnancy
- 8. Autoimmune Thyroid Disease in Pregnancy: Clinical Implications for Miscarriage Risk